Follow
Kirubakaran Palani
Kirubakaran Palani
Postdoctoral Associate, Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, United States
Verified email at fccc.edu
Title
Cited by
Cited by
Year
Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease
KD Singh, P Kirubakaran, S Nagarajan, S Sakkiah, K Muthusamy, ...
Journal of molecular modeling 18, 39-51, 2012
1052012
Rationalizing PROTAC-mediated ternary complex formation using Rosetta
N Bai, SA Miller, GV Andrianov, M Yates, P Kirubakaran, J Karanicolas
Journal of chemical information and modeling 61 (3), 1368-1382, 2021
812021
Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors
KD Singh, M Karthikeyan, P Kirubakaran, S Nagamani
Journal of Molecular Graphics and Modelling 30, 186-197, 2011
552011
Exquisite ligand stereoselectivity of a Drosophila juvenile hormone receptor contrasts with its broad agonist repertoire
L Bittova, P Jedlicka, M Dracinsky, P Kirubakaran, J Vondrasek, R Hanus, ...
Journal of Biological Chemistry 294 (2), 410-423, 2019
392019
Ligand-based pharmacophore modeling; atom-based 3D-QSAR analysis and molecular docking studies of phosphoinositide-dependent kinase-1 inhibitors
P Kirubakaran, K Muthusamy, KHD Singh, S Nagamani
Indian Journal of Pharmaceutical Sciences 74 (2), 141, 2012
242012
Sighting of tankyrase inhibitors by structure-and ligand-based screening and in vitro approach
P Kirubakaran, P Arunkumar, K Premkumar, K Muthusamy
Molecular BioSystems 10 (10), 2699-2712, 2014
222014
Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactions
P Kirubakaran, G Kothandan, SJ Cho, K Muthusamy
Molecular BioSystems 10 (2), 281-293, 2014
212014
In silico structural and functional analysis of the human TOPK protein by structure modeling and molecular dynamics studies
P Kirubakaran, M Karthikeyan, KD Singh, S Nagamani, K Premkumar
Journal of molecular modeling 19, 407-419, 2013
192013
In silico studies on marine actinomycetes as potential inhibitors for Glioblastoma multiforme
P Kirubakaran, R Kothapalli, KD Singh, S Nagamani, S Arjunan, ...
Bioinformation 6 (3), 100, 2011
182011
Pharmacophore modeling, 3D-QSAR and DFT studies of IWR small-molecule inhibitors of Wnt response
P Kirubakaran, M Karthikeyan
Journal of Receptors and Signal Transduction 33 (5), 276-285, 2013
142013
Homology modeling, molecular dynamics, and molecular docking studies of Trichomonas vaginalis carbamate kinase
P Kirubakaran, K Muthusamy, K Dhanachandra Singh, S Nagamani
Medicinal Chemistry Research 21, 2105-2116, 2012
132012
Substituents at the C3′ and C3′ N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel
M Jelínek, K Balušíková, P Daniel, V Němcová-Fürstová, P Kirubakaran, ...
Toxicology and applied pharmacology 347, 79-91, 2018
122018
Theoretical studies on benzimidazole derivatives as E. coli biotin carboxylase inhibitors
S Nagamani, K Muthusamy, P Kirubakaran, KD Singh, G Krishnasamy
Medicinal Chemistry Research 21 (9), 2169-2180, 2012
92012
Understanding the evolutionary relationship of hemagglutinin protein from influenza viruses using phylogenetic and molecular modeling studies
M Karthikeyan, P Kirubakaran, KD Singh, B Sampath, G Krishnasamy
Journal of Biomolecular Structure and Dynamics 32 (5), 816-830, 2014
82014
The identification of new substrates of human DHRS7 by molecular modeling and in vitro testing
L Zemanová, P Kirubakaran, IH Pato, H Štambergová, J Vondrášek
International journal of biological macromolecules 105, 171-182, 2017
72017
Artificial proteins as allosteric modulators of PDZ3 and SH3 in two‐domain constructs: a computational characterization of novel chimeric proteins
P Kirubakaran, L Pfeiferová, K Boušová, L Bednarova, V Obšilová, ...
Proteins: Structure, Function, and Bioinformatics 84 (10), 1358-1374, 2016
62016
Docking studies of adenosine analogues with NS5 methyltransferase of yellow fever virus
K Dhanachandra Singh, P Kirubakaran, S Manikandaprabhu, ...
Indian journal of microbiology 52, 28-34, 2012
52012
Comparative modeling of CDK9 Inhibitors to explore selectivity and structure-activity relationships
P Kirubakaran, G Morton, P Zhang, H Zhang, J Gordon, M Abou-Gharbia, ...
bioRxiv, 2020.06. 08.138602, 2020
42020
Pharmacophore modeling, 3D-QSAR, and molecular docking study on naphthyridine derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1
P Kirubakaran, K Muthusamy, K Dhanachandra Singh, S Nagamani
Medicinal Chemistry Research 22 (8), 3812-3822, 2013
42013
Structure-based drug discovery of ApoE4 inhibitors from the plant compounds
K Dhanachandra Singh, M Karthikeyan, P Kirubakaran, V Sathya, ...
Medicinal Chemistry Research 21, 825-833, 2012
42012
The system can't perform the operation now. Try again later.
Articles 1–20